Crossmark

Selective CDK4 inhibition holds promise for breast cancer

Crossref DOI link: https://doi.org/10.1038/s41422-025-01117-4

Published Online: 2025-04-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beltrán-Visiedo, Manuel

Shulman, Rebecca M.

Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
License Information

Text and Data Mining valid from 2025-04-14

Version of Record valid from 2025-04-14
More Information

Article History

First Online: 14 April 2025

Competing interests

: The authors declare no competing interests.